The global API market was valued at USD 179.2 billion in 2025 and is projected to reach USD 290.5 billion by 2033, growing at a CAGR of 6.3% during the forecast period. Rising prevalence of chronic diseases, increased demand for generic drugs, and growing pharmaceutical research and development activities are driving market expansion globally.